Literature DB >> 14724558

Declining prevalence of no known major risk factors for heart disease and stroke among adults--United States, 1991-2001.

.   

Abstract

Despite declines in recent years, heart disease and stroke remain the first and third leading causes of death in the United States, respectively. Of all U.S. deaths in 2001, heart disease accounted for 29.0% and stroke for 6.8%. The major risk factors for both conditions are high blood pressure, high cholesterol, diabetes, smoking, and obesity, all of which have been targeted by national prevention programs. In addition, the prevalence of multiple major risk factors has been a matter of increasing concern. However, few studies of national and state-level data have examined the prevalence of no known major risk factors among adults and how that prevalence has changed during the preceding 10 years. To assess changes in prevalence of no known risk factors for heart disease and stroke during 1991-2001, CDC analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results of that analysis, which indicate that prevalence of no known major risk factors is decreasing among men and women in nearly all states, racial/ethnic populations, age groups, and education levels. In addition, the prevalence of individual major risk factors is increasing. These findings underscore the potential for an increased burden of heart disease and stroke on the health-care system. To prevent the debilitating outcomes of heart disease and stroke among the aging U.S. population, increased prevention efforts and treatment interventions are needed.

Entities:  

Mesh:

Year:  2004        PMID: 14724558

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  The emerging link between alcoholism risk and obesity in the United States.

Authors:  Richard A Grucza; Robert F Krueger; Susan B Racette; Karen E Norberg; Pamela R Hipp; Laura J Bierut
Journal:  Arch Gen Psychiatry       Date:  2010-12

2.  Psychological and social support associations with mortality and cardiovascular disease in middle-aged American Indians: the Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Harry Eyituoyo; Marcia O'Leary; Shelley A Cole; Aminata Traore; Steve Verney; Barbara Howard; Spero Manson; Dedra Buchwald; Paul Whitney
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-14       Impact factor: 4.519

Review 3.  Epidemiology and burden of cardiovascular disease.

Authors:  Laurence O Watkins
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

4.  Drinking carrot juice increases total antioxidant status and decreases lipid peroxidation in adults.

Authors:  Andrew S Potter; Shahrzad Foroudi; Alexis Stamatikos; Bhimanagouda S Patil; Farzad Deyhim
Journal:  Nutr J       Date:  2011-09-24       Impact factor: 3.271

Review 5.  Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination.

Authors:  Ryan C Neal; Peter H Jones
Journal:  Vasc Health Risk Manag       Date:  2006

6.  Ethnic variation in validity of classification of overweight and obesity using self-reported weight and height in American women and men: the Third National Health and Nutrition Examination Survey.

Authors:  R F Gillum; Christopher T Sempos
Journal:  Nutr J       Date:  2005-10-06       Impact factor: 3.271

7.  Decreasing prevalence of no known major risk factors for cardiovascular disease among Mississippi adults, Mississippi Behavioral Risk Factor Surveillance System, 2001 and 2009.

Authors:  Vincent L Mendy; Rodolfo Vargas; Lamees El-Sadek; Vanessa L Short
Journal:  BMC Public Health       Date:  2016-12-03       Impact factor: 3.295

8.  Adherence of cardiologist physicians to the American Heart Association guideline in approach to risk factors of cardiovascular diseases: An experience from a teaching hospital.

Authors:  Zarrintaj Hosseinzadeh-Shanjani; Soodabeh Hoveidamanesh; Mozhdeh Ramezani; Farnoush Davoudi; Marzieh Nojomi
Journal:  ARYA Atheroscler       Date:  2019-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.